SLC2A1 and Its Related Epileptic Phenotypes

被引:1
|
作者
Patane, Francesca [1 ]
Pasquetti, Elisa [1 ]
Sullo, Federica [1 ]
Tosto, Monica [1 ]
Romano, Catia [2 ]
Salafia, Stefania [3 ]
Falsaperla, Raffaele [4 ,5 ]
机构
[1] Univ Catania, Dept Clin & Expt Med, Sect Pediat & Child Neuropsychiat, Pediat Postgrad Residency Program, Catania, Italy
[2] Italian Blind Union, Catania Sect, Catania, Italy
[3] Lentini Hosp, Unit Pediat, I-96016 Contrada Colle Roggio, Lentini, Italy
[4] Univ Hosp Policlin Rodolico San Marco, Unit Pediat & Pediat Emergency, Catania, Italy
[5] Univ Hosp Policlin Rodolico San Marco, Unit Neonatal Intens Care & Neonatol, Catania, Italy
关键词
SLC2A1; epilepsy; microcephaly; movement disorders; ketogenic diet; GLUT1 DEFICIENCY SYNDROME; CHILDHOOD NEUROFIBROMATOSIS TYPE-2; GLUCOSE-TRANSPORTER-1; DEFICIENCY; MEDICAL CURIOSITIES; ABSENCE EPILEPSY; NATURAL-HISTORY; TREATABLE CAUSE; KETOGENIC DIET; MUTATIONS; BRAIN;
D O I
10.1055/s-0041-1728668
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Glucose transporter type 1 deficiency syndrome (GLUT1DS) is caused by heterozygous, mostly de novo, mutations in SLC2A1 gene encoding the glucose transporter GLUT1, the most relevant energy transporter in the blood-brain barrier. GLUT1DS includes a broad spectrum of neurologic disturbances, from severe encephalopathy with developmental delay, to epilepsy, movement disorders, acquired microcephaly and atypical mild forms. For diagnosis, lumbar puncture and genetic analysis are necessary and complementary; an immediate response to ketogenic diet supports the diagnosis in case of high suspicion of disease and negative exams. The ketogenic diet is the first-line treatment and should be established at the initial stages of disease.
引用
收藏
页数:7
相关论文
共 50 条
  • [11] Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes
    Castellotti, Barbara
    Ragona, Francesca
    Freri, Elena
    Solazzi, Roberta
    Ciardullo, Stefano
    Tricomi, Giovanni
    Venerando, Anna
    Salis, Barbara
    Canafoglia, Laura
    Villani, Flavio
    Franceschetti, Silvana
    Nardocci, Nardo
    Gellera, Cinzia
    DiFrancesco, Jacopo C.
    Granata, Tiziana
    JOURNAL OF NEUROLOGY, 2019, 266 (06) : 1439 - 1448
  • [12] Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes
    Barbara Castellotti
    Francesca Ragona
    Elena Freri
    Roberta Solazzi
    Stefano Ciardullo
    Giovanni Tricomi
    Anna Venerando
    Barbara Salis
    Laura Canafoglia
    Flavio Villani
    Silvana Franceschetti
    Nardo Nardocci
    Cinzia Gellera
    Jacopo C. DiFrancesco
    Tiziana Granata
    Journal of Neurology, 2019, 266 : 1439 - 1448
  • [13] Steroids Regulate SLC2A1 and SLC2A3 to Deliver Glucose Into Trophectoderm for Metabolism via Glycolysis
    Kramer, Avery C.
    Steinhauser, Chelsie B.
    Gao, Haijun
    Seo, Heewon
    McLendon, Bryan A.
    Burghardt, Robert C.
    Wu, Guoyao
    Bazer, Fuller W.
    Johnson, Greg A.
    ENDOCRINOLOGY, 2020, 161 (08)
  • [14] Steroids Regulate SLC2A1 and SLC2A3 to Deliver Glucose into Trophectoderm for Metabolism via Glycolysis
    Johnson, Gregory A.
    Kramer, Avery C.
    Steinhauser, Chelsie
    Seo, Heewon
    McLendon, Bryan A.
    Burghardt, Robert C.
    Wu, Guoyao
    Bazer, Fuller W.
    JOURNAL OF ANIMAL SCIENCE, 2020, 98 : 188 - 188
  • [15] SLC2A1 Polymorphism Decreases Incidence of Depression and PTSD after Trauma
    Neigh, Gretchen
    Jovanovic, Tanja
    Smith, Alicia
    Almli, Lynn
    Gillespie, Charles
    Kilaru, Varun
    Harrell, Constance
    Ressler, Kerry
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S423 - S423
  • [16] Developmental outcomes and prevalence of SLC2A1 variants in young infants with hypoglycorrhachia
    Yu, Wen-Hao
    Chen, Li-Wen
    Wang, Shan-Tair
    Tu, Yi-Fang
    Huang, Chao-Ching
    BRAIN & DEVELOPMENT, 2019, 41 (10): : 854 - 861
  • [17] SLC2A1 Tag SNPs in Greek Patients with Diabetic Retinopathy and Nephropathy
    Siokas, Vasileios
    Fotiadou, Anatoli
    Dardiotis, Efthimios
    Kotoula, Maria G.
    Tachmitzi, Sophia V.
    Chatzoulis, Dimitrios Z.
    Zintzaras, Elias
    Stefanidis, Ioannis
    Tsironi, Evangelia E.
    OPHTHALMIC RESEARCH, 2019, 61 (01) : 26 - 35
  • [18] Expression of glucose transporters SLC2A1, SLC2A8, and SLC2A12 in different chicken muscles during ontogenesis
    Coudert, Edouard
    Praud, Christophe
    Dupont, Joelle
    Crochet, Sabine
    Cailleau-Audouin, Estelle
    Bordeau, Thierry
    Godet, Estelle
    Collin, Anne
    Berri, Cecile
    Tesseraud, Sophie
    Metayer-Coustard, Sonia
    JOURNAL OF ANIMAL SCIENCE, 2018, 96 (02) : 498 - 509
  • [19] SLC2A1 induction by methotrexate as basis for synergistic therapeutic approaches in osteosarcoma
    Dietachmayr, M.
    Eichner, R.
    Kartnig, F.
    Sedlyarov, V.
    Goldmann, U.
    Pemovska, T.
    Stucht, A.
    Specht, K.
    Steiger, K.
    Bassermann, F.
    Superti-Furga, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 156 - 157
  • [20] SLC2A1 Polymorphism Decreases Incidence of Depression and PTSD after Trauma
    Neigh, Gretchen N.
    Jovanovic, Tanja
    Smith, Alicia
    Almli, Lynn
    Gillespie, Charles
    Kilaru, Varun
    Harrell, Constance
    Ressler, Kerry
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 225S - 225S